Description

4H-Imidazo[1,5-A][1,4]Benzodiazepine-3-Carboxylicacid, 5,6-Dihydro-8-Hydroxy-5-Methyl-6-Oxo-, Ethyl Ester is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly for synthesizing novel therapeutic agents. It is primarily needed by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new active pharmaceutical ingredients (APIs) and exploring structure-activity relationships.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of novel benzodiazepine and imidazobenzodiazepine analogs with potential therapeutic applications.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new drug candidates targeting the central nervous system (CNS).
• API Development: Serves as a critical precursor in the multi-step synthesis of complex target molecules for pre-clinical and clinical trials.
• Biochemical Research: Potential tool compound for studying specific receptor interactions and biochemical pathways in academic and industrial research settings.
• Fine Chemical Synthesis: Employed in custom synthesis and contract manufacturing for producing specialized, high-value chemical entities.

Basic Information

Product Name	4H-Imidazo[1,5-A][1,4]Benzodiazepine-3-Carboxylicacid, 5,6-Dihydro-8-Hydroxy-5-Methyl-6-Oxo-, Ethyl Ester
CAS No.	131666-45-0
Molecular Formula	C16H15N3O4
Molecular Weight	313.31 g/mol
Synonyms	Ethyl 5,6-dihydro-8-hydroxy-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate; 8-Hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester; L-655,708; L655708; FG 8094; Imidazobenzodiazepine carboxyethyl ester; 4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 5,6-dihydro-8-hydroxy-5-methyl-6-oxo-, ethyl ester
EINECS	Contact for details

Quality Control

Our 4H-Imidazo[1,5-A][1,4]Benzodiazepine-3-Carboxylicacid, 5,6-Dihydro-8-Hydroxy-5-Methyl-6-Oxo-, Ethyl Ester is manufactured under strict quality management systems. The product undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing batch-specific results are available upon request to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The compound is light-sensitive and should be handled and stored accordingly to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single unknown impurity	≤ 0.5%
Residual Solvents (GC)	Meets ICH guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.